What does TriSalus Life Sciences, Inc. do?
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD)…
What is TriSalus Life Sciences, Inc.'s P/E and P/B ratio?
TriSalus Life Sciences, Inc. has a P/E ratio of -3.0 and a P/B ratio of 34.41.
What is TriSalus Life Sciences, Inc.'s debt-to-equity ratio?
TriSalus Life Sciences, Inc. has a debt-to-equity ratio of 5.26.
How much does TriSalus Life Sciences, Inc. owe compared with what it owns?
TriSalus Life Sciences, Inc. owes $0.90 for every $1 it owns (balance sheet Jun 2026), which is high.
What is TriSalus Life Sciences, Inc.'s Positivity rank?
TriSalus Life Sciences, Inc. is ranked #6,265 of 6,774 companies globally and #3,571 of 4,000 in United States on PositoAI, with a Positivity Score of 594.
Does TriSalus Life Sciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for TriSalus Life Sciences, Inc..
Where can I read the latest news about TriSalus Life Sciences, Inc.?
Recent headlines about TriSalus Life Sciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does TriSalus Life Sciences, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of TriSalus Life Sciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.